Investigational drug · Phase 3
HSK3486
Not approved by FDA. In 1 industry-sponsored Phase 2 or 3 trial that is active or finished in the last two years, most often for General Anesthetic.
Phase 3Last checked: Nov 19, 2026Latest source record: Apr 6, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 3
Industry-sponsored trials
Phase 2 and 3 trials
1
1 still active
All registered trials
36
Any phase or sponsor naming "HSK3486"
First trial start
2026
May 2026
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "HSK3486", any sponsor or status.
- Phase 116
Conditions studied
As listed on its trial records.
- General Anesthetic
Approved drugs for the same conditions: Pain and anesthesia
Largest trials
Live from ClinicalTrials.gov: studies naming "HSK3486" as an intervention, largest first.
- Effects of Ciprofol on Myocardial Injury After Non-cardiac Surgery in Video-Assisted Thoracoscopic SurgeryPivotal-lookingRecruiting
Tongji HospitalAcademic, hospital or other
NCT07028593 · 1,058 participants (planned) · Start Jul 31, 2025 · Primary completion Oct 2027
Drug: Propofol; ciprofol · For: Myocardial Injury; Thoracic Diseases; Thoracoscopic Surgery
Sites: Wuhan, China
- Safety and Efficacy of HSK3486 Compared to Propofol for Induction of General Anesthesia in Adults With Elective SurgeryPivotal-lookingCompleted
Haisco-USA Pharmaceuticals, Inc.Industry
NCT05486416 · 465 participants · Start Jan 12, 2024 · Primary completion Jul 23, 2024
Drug: HSK3486; Propofol · For: General Anesthesia
Sites: Florence, Alabama; Sheffield, Alabama; Miami, Florida · 28 sites in all
- HSK3486 (Cipepofol) Injectable Emulsion for Induction of General Anesthesia in Pediatric Subjects Undergoing Elective SurgeryPivotal-lookingNot yet recruiting
Haisco Pharmaceutical Group Co., Ltd.Industry
NCT07510945 · 400 participants (planned) · Start May 2026 · Primary completion May 2028
Drug: HSK3486; propofol · For: General Anesthetic
- Efficacy and Safety of HSK3486 Compared to Propofol for Adults Undergoing Elective Surgery With General AnesthesiaPivotal-lookingCompleted
Haisco-USA Pharmaceuticals, Inc.Industry
NCT05478174 · 400 participants · Start Jul 26, 2022 · Primary completion Nov 7, 2023
Drug: HSK3486; Propofol · For: General Anesthesia
Sites: Sheffield, Alabama; Phoenix, Arizona; Davis, California · 23 sites in all
- A Phase III Study Evaluating The Efficacy and Safety of HSK3486 for Sedation or AnesthesiaPivotal-lookingCompleted
Sichuan Haisco Pharmaceutical Group Co., LtdIndustry
NCT03674008 · 280 participants · Start Oct 9, 2018 · Primary completion Jan 9, 2019
Drug: HSK3486; Propofol · For: Sedation or Anesthesia
Sites: Changde, China
- Comparison of Ciprofol-based and Propofol-based Total Intravenous Anesthesia on Postoperative Quality of RecoveryPivotal-lookingStatus unknown
Xijing HospitalAcademic, hospital or other
NCT05843383 · 280 participants (planned) · Start May 16, 2023 · Primary completion Dec 1, 2024
Drug: Ciprofol; Propofol · For: Anesthetics, Intravenous; Postoperative Complications; Hypnotics and Sedatives and 1 more
Sites: Xi'an, China · 2 sites in all
- A Trial Evaluating the Efficacy and Safety of HSK3486 Injectable Emulsion in Subjects Undergoing Fiberoptic BronchoscopyPivotal-lookingCompleted
Sichuan Haisco Pharmaceutical Group Co., LtdIndustry
NCT04111159 · 267 participants · Start Dec 6, 2019 · Primary completion Jun 19, 2020
Drug: HSK3486; Propofol · For: Sedation or Anesthesia
Sites: Chengdu, China
- Efficacy and Safety of HSK3486 Compared to Propofol in Induction of General Anesthesia in Adults Having Elective SurgeryPivotal-lookingCompleted
Haisco-USA Pharmaceuticals, Inc.Industry
NCT04711837 · 255 participants · Start Feb 11, 2021 · Primary completion Apr 13, 2022
Drug: HSK3486; Propofol · For: Anesthesia
Sites: Phoenix, Arizona; Pasadena, California; Tamarac, Florida · 13 sites in all
- A Trial Evaluating the Efficacy and Safety of HSK3486 Injectable Emulsion for the Induction of General Anesthesia in Elective Surgery SubjectsPivotal-lookingCompleted
Sichuan Haisco Pharmaceutical Group Co., LtdIndustry
NCT03808844 · 178 participants · Start Mar 22, 2019 · Primary completion Aug 14, 2019
Drug: HSK3486; Propofol · For: Induction of Anesthesia
Sites: Chengdu, China
- A Study Evaluating Sedation of Intravenous Administration of HSK3486 Injectable Emulsion in ICU Patients Undergoing Mechanical VentilationPivotal-lookingCompleted
Haisco Pharmaceutical Group Co., Ltd.Industry
NCT04620031 · 135 participants · Start Dec 8, 2020 · Primary completion Jun 2, 2021
Drug: HSK3486; Propofol · For: Sedation in Intensive Care
Sites: Guangzhou, China
Newest research
PubMed records naming it or its code names, newest first.
- Development and Evaluation of a Physiologically Based Pharmacokinetic Model for Cipepofol Across Diverse Clinical Populations.
Li J, Li L, Ding F, et al. · Pharmaceutics 2026
- Comparison of ciprofol and propofol on dreaming and emotional response during painless gastroscopy: a single-center randomized controlled trial.
Xiong L, Li K, Feng X, et al. · Expert Opin Drug Saf 2026
- Advantages of Ciprofol with Special Consideration of Pediatric Anesthesia.
Vittori A, Di Fabio C, Cascella M, et al. · Children (Basel) 2026
- Effects of Cipepofol on Cardiac Depolarization and Repolarization in Healthy Subjects: A Single-Center, Randomized, Placebo and Positive-Controlled Thorough QT Study.
Kleiman R, Rudo T, Daley W, et al. · Drug Des Devel Ther 2026
- Effects of Voriconazole on the Safety, Pharmacokinetics and Pharmacodynamics of Ciprofol (HSK3486), a Novel Intravenous Anaesthetic, in Healthy Participants: A Prospective, Randomized, Crossover Clinical Trial.
Bian Y, Hu T, Deng Q, et al. · Drug Des Devel Ther 2026
- Ciprofol versus Propofol for General Anesthesia Induction in Major Orthopedic Surgery: Efficacy and Safety Analyses Pertaining to Anesthetic Parameters.
Yao X, Wang H, Zhang Y, et al. · Pharmacology 2026
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.